[go: up one dir, main page]

WO2010062034A3 - 유럽종 포도의 씨 추출물을 함유하는 점안용 액제 또는 겔제 형태의 약학 조성물 - Google Patents

유럽종 포도의 씨 추출물을 함유하는 점안용 액제 또는 겔제 형태의 약학 조성물 Download PDF

Info

Publication number
WO2010062034A3
WO2010062034A3 PCT/KR2009/005750 KR2009005750W WO2010062034A3 WO 2010062034 A3 WO2010062034 A3 WO 2010062034A3 KR 2009005750 W KR2009005750 W KR 2009005750W WO 2010062034 A3 WO2010062034 A3 WO 2010062034A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
eye drop
seed extract
gel type
vitis vinifera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/005750
Other languages
English (en)
French (fr)
Other versions
WO2010062034A2 (ko
Inventor
박세완
이근혁
류종현
김재신
박진하
곽은영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanlim Pharmaceutical Co Ltd
Original Assignee
Hanlim Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanlim Pharmaceutical Co Ltd filed Critical Hanlim Pharmaceutical Co Ltd
Publication of WO2010062034A2 publication Critical patent/WO2010062034A2/ko
Publication of WO2010062034A3 publication Critical patent/WO2010062034A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 유럽종 포도(Vitis vinifera)의 씨 추출물; 및 아스코르브산 또는 그의 염, 아황산수소나트륨, 피로아황산칼륨, 및 L-트레오닌 또는 그의 염으로 이루어진 군으로부터 선택된 항산화제를 포함하는, 점안용 액제 또는 겔제 형태의 약학 조성물을 제공한다. 본 발명에 따른 약학 조성물은 장기간 동안 물리적 및 화학적 안정성을 유지할 수 있으며, 따라서, 장기간 동안의 보관이 가능하므로, 제약분야에 유용하게 적용될 수 있다.
PCT/KR2009/005750 2008-11-28 2009-10-08 유럽종 포도의 씨 추출물을 함유하는 점안용 액제 또는 겔제 형태의 약학 조성물 Ceased WO2010062034A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080119366A KR101047356B1 (ko) 2008-11-28 2008-11-28 유럽종 포도의 씨 추출물을 함유하는 점안용 액제 또는 겔제 형태의 약학 조성물
KR10-2008-0119366 2008-11-28

Publications (2)

Publication Number Publication Date
WO2010062034A2 WO2010062034A2 (ko) 2010-06-03
WO2010062034A3 true WO2010062034A3 (ko) 2010-08-19

Family

ID=42226198

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/005750 Ceased WO2010062034A2 (ko) 2008-11-28 2009-10-08 유럽종 포도의 씨 추출물을 함유하는 점안용 액제 또는 겔제 형태의 약학 조성물

Country Status (2)

Country Link
KR (1) KR101047356B1 (ko)
WO (1) WO2010062034A2 (ko)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100281477B1 (ko) * 1992-05-11 2001-02-01 팔리안티 쥬세뻬 안토시아노사이드를 함유하는 경구용 약제학적 조성물
WO2003086442A2 (en) * 2002-04-04 2003-10-23 Natural Disinfectant Technologies Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives
WO2007127844A2 (en) * 2006-04-28 2007-11-08 Alcon, Inc. Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
WO2008007244A2 (en) * 2006-06-08 2008-01-17 The Iams Company Composition for improving eye health

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100281477B1 (ko) * 1992-05-11 2001-02-01 팔리안티 쥬세뻬 안토시아노사이드를 함유하는 경구용 약제학적 조성물
WO2003086442A2 (en) * 2002-04-04 2003-10-23 Natural Disinfectant Technologies Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives
WO2007127844A2 (en) * 2006-04-28 2007-11-08 Alcon, Inc. Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
WO2008007244A2 (en) * 2006-06-08 2008-01-17 The Iams Company Composition for improving eye health

Also Published As

Publication number Publication date
KR101047356B1 (ko) 2011-07-07
KR20100060673A (ko) 2010-06-07
WO2010062034A2 (ko) 2010-06-03

Similar Documents

Publication Publication Date Title
BR112014009031A2 (pt) formulações de etanercept estabilizadas com íons de metais
WO2012153193A3 (en) Protein-active agent conjugates and method for preparing the same
MX2009011165A (es) Formulaciones farmaceuticas que contienen derivados del acido lipoico.
EA028156B9 (ru) Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
EA201170958A1 (ru) Твердая фармацевтическая композиция, содержащая амлодипин и лозартан, и способ ее получения
EP2486793A3 (en) Stable S-(+)-abscisic acid liquid and soluble granule formulations
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
TW200833351A (en) New cosmetic and/or pharmaceutical compositions and their applications
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
ZA202210899B (en) Solutons for increasing the stability and shelf life of an organ and tissue preservation solution
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
WO2010025859A3 (de) Stabilisierung von zellen durch ionische flüssigkeiten
DE602007014206D1 (de) Neuartige serotonin-wiederaufnahmehemmer als arzneimittel mit peripheriesystem-beschränkter aktivität
WO2010056527A3 (en) B-biphenyl sulfonamide compounds as ion channel modulators
GEP20135859B (en) Stable combined pharmaceutical composition
WO2008065282A3 (fr) Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation
WO2009129208A3 (en) Compositions and methods of inducing endoplasmic reticulum stress reponse
WO2012033390A3 (en) Novel thiophene derivative as sglt2 inhibitor and pharmaceutical composition comprising same
IN2015DN02596A (ko)
EA201001353A1 (ru) Гидробромид ивабрадина
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
WO2013022312A3 (ko) C y p 4 a 저해제를 유효성분으로 함유하는 당뇨병 또는 지방간의 예방 또는 치료용 약학적 조성물
WO2010062034A3 (ko) 유럽종 포도의 씨 추출물을 함유하는 점안용 액제 또는 겔제 형태의 약학 조성물
EA201300882A1 (ru) Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс (варианты), набор и лекарственное средство
WO2011041609A3 (en) Topical formulations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09829241

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09829241

Country of ref document: EP

Kind code of ref document: A2